← 產業報告目錄
Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users, And Distribution Channels, Region And Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 168報告編號 INSIGHTACE-025458df01
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Celiac Disease Market on a global scale was estimated at USD 581.6 Mn in 2023 and is forecasted to attain USD 1,195.5 Mn by 2031, with a projected CAGR of 9.8% between 2024 and 2031.
At its core, Celiac Disease pertains to an autoimmune disorder in which gluten consumption triggers an immune response that destroys the small intestine lining. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
Market momentum is propelled by growing interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Celiac Disease Market Snapshot
Chapter 4. Global Celiac Disease Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Celiac Disease Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Celiac Disease Industry Trends
Chapter 5. Celiac Disease Market Segmentation 1: By Treatments, Estimates & Trend Analysis
5.1. Market Share by Treatments, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Treatments:
5.2.1. Infliximab
5.2.2. Larazotide Acetate
5.2.3. Gluten Free Diet
5.2.4. Others
Chapter 6. Celiac Disease Market Segmentation 2: By Route of Administrations, Estimates & Trend Analysis
6.1. Market Share by Route of Administrations, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Route of Administrationss:
6.2.1. Oral
6.2.2. Parenteral
Chapter 7. Celiac Disease Market Segmentation 3: By Distribution Channels, Estimates & Trend Analysis
7.1. Market Share by Distribution Channels, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channelss:
7.2.1. Hospital Pharmacy
7.2.2. Online Pharmacy
7.2.3. Retail Pharmacy
Chapter 8. Celiac Disease Market Segmentation 4: By End-Users Industry, Estimates & Trend Analysis
8.1. Market Share by End-Users Industry, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-Users Industrys:
8.2.1. Hospitals
8.2.2. Homecare
8.2.3. Others
Chapter 9. Celiac Disease Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Celiac Disease Market, Regional Snapshot 2023 & 2031
9.2. North America
9.2.1. North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031
9.2.3. North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031
9.2.4. North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031
9.2.5. North America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031
9.3. Europe
9.3.1. Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031
9.3.3. Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031
9.3.4. Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031
9.3.5. Europe Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031
9.4. Asia Pacific
9.4.1. Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031
9.4.3. Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031
9.4.4. Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2024-2031
9.4.5. Asia Pacific Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031
9.5. Latin America
9.5.1. Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031
9.5.3. Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031
9.5.4. Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031
9.5.5. Latin America Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031
9.6. Middle East & Africa
9.6.1. Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Treatments, 2024-2031
9.6.3. Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Route of Administrations, 2024-2031
9.6.4. Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channels, 2024-2031
9.6.5. Middle East & Africa Celiac Disease Market Revenue (US$ Million) Estimates and Forecasts by End-Users Industry, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Amgen
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial PerTreatmentsance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Anokion SA
10.2.3. BioLineRx Ltd
10.2.4. ChemoCentryx, Inc
10.2.5. COUR Pharmaceutical
10.2.6. F. Hoffmann-La Roche Ltd
10.2.7. ImmunogenX, LLC
10.2.8. Innovate Biopharmaceuticals
10.2.9. Takeda Pharmaceutical Company Limited
10.2.10. Teva Pharmaceutical Industries Ltd (Israel)
10.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們